The newly formed SAB will provide strategic direction across research, clinical development, and regulatory pathways
The study was conducted by PwC India in line with ISO 14040 and ISO 14044 protocols
The innovation is particularly suited for bone and cartilage repair
The company allocated €56 million to research and development for next-generation line solutions
New purpose-built AI model targets faster R&D cycles and deeper scientific insights across life sciences
Discussions will focus on how private space stations can improve access, repeatability and commercial feasibility for advanced biotech experiments
The collaboration combines Alveus’ expertise in metabolic biology and therapeutic strategy with Aurigene’s integrated discovery capabilities
The CE Mark builds on the company’s ISO 13485 certification, further strengthening confidence in the platform's safety, quality and performance
The upcoming multi-center, multinational Phase 1 study will evaluate safety, tolerability, pharmacokinetics, and early signs of efficacy
Strategic expansion strengthens CDMO’s support for biotech and pharma innovators across the Asia-Pacific region
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
